doi:https://doi.org/

Journal: Evidence-based Cardiology. 2013;(1): 21‑23

Read: 6689 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

. Evidence-based Cardiology. 2013;(1):21‑23. (In Russ.)

Использование инфографики авторами научных работ

References:

Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894-2900.
O'Keefe J.H., McCallister B.D., Bateman T.M., et al. Ineffectiveness of colchicine for the prevention of restenosisafter coronary angioplasty. J Am Coll Cardiol 1992;19:1597-1600.
Schattner A. Colchicine - expanding horizons. Postgrad Med J 1991;67:223-226.
Langevitz P., Livneh A., Neumann L., et al. Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 2000;2:9-12.
Crittenden D.B., Lehmann R.A., Schneck L., et al. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. J Rheumatol 2012;39:1458-1464.
Nidorf S.M., Thompson P.L. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. Am J Cardiol 2007;99:805-807.
Imazio M., Cecchi E., Demarie D., et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the Colchicine for Acute Pericarditis (COPE) trial. Circulation 2005;112:2012-2016.
Kallinich T., Haffner D., Niehues T., et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007;119:e474-e483.
Alayli G., Cengiz K., Canturk F., et al. Acute myopathy in a patient with concomitant use of pravastatin and colchicine. Ann Pharmacother 2005;39:1358-1361.
Stone G.W., Maehara A., Lansky A.J., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235.